Are you looking for a CDMO partner to move your programme to clinics?
Connect with our team and we will get back to you shortly.
GTP Biologics offers GMP manufacturing for recombinant proteins, antibodies and bioconjugates for preclinical and clinical studies.
With our cGMP manufacturing services, you'll have complete serenity when it comes to the clinical development of your protein or mAb therapeutic.
Through our strong partnership, GTP Technology and GTP Biologics (a Fareva affiliate) can support your biotherapeutics projects from cell line development to drug substance (DS) manufacturing for your clinical studies.
GTP Biologics’ state-of-the-art mammalian cGMP manufacturing facilities are located in Saint-Julien-en-Genevois, France. The GMP production unit offers capacities ranging from 250L to 1000L in a fully-equipped class D suite. The manufacturing process is based on single-use technologies to reduce cross-contamination and manufacturing time.
With over 15 years’ experience in mammalian GMP manufacturing and a 100% success rate in bringing a variety of biomolecules into clinic, including monoclonal antibodies and antibody-drug conjugates, the GTP Biologics team is uniquely placed to support your project.
The seasoned QA team at GTP Biologics will ensure a reproducible quality and high safety at each production step. In addition, GTP Biologics offers a wide variety of in-house analytical testing and release capabilities to master your deadlines.
Thanks to its qualified staff with a longstanding experience of biotherapeutics development in pharmaceutical companies, the GTP Biologics team is familiar with IMPD/IND application filings and ready to assist you in the completion of these regulatory documents.
Our activities cover the full development cycle of your biotherapeutics thanks to a strong partnership with V-nano, our sister company. V-nano is a CDMO located in Toulouse, France offering cGMP manufacturing of sterile drug products in liquid forms.
V-nano owns a worldwide unique robotics solution with fully automated filling and stoppering in a single-use isolator. Their capacities go up to 10,000 units per batch whatever the container type (vials and pre-filled syringes).
GTP’s activities cover the full development cycle of your biotherapeutics, from supporting early-stage discovery through small-scale protein production to cGMP manufacturing.